TerraPower Isotopes’ Chris Dunckley Leads Team Extracting Ultra-Rare Actinium-225 from Cold War Waste for Cancer Therapy
Chris Dunckley, director of chemistry and engineering at TerraPower Isotopes, leads a multidisciplinary team extracting the ultra-rare radioisotope actinium-225 from Cold War nuclear waste to develop promising cancer therapies. His leadership and scientific expertise help transform radioactive weapons waste into potentially life-saving medical treatments.
T
A
U
No comments yet.